Effect of 5-Aminolevulinic Acid (5-ALA) in "ALADENT" Gel Formulation and Photodynamic Therapy (PDT) against Human Oral and Pancreatic Cancers.
5-aminolevulinic acid
CAL-27
CAPAN-2
apoptosis
cell cycle
oral cancer
pancreatic cancer
photodynamic therapy
protoporphyrin
reactive oxygen species
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
13 Jun 2024
13 Jun 2024
Historique:
received:
13
05
2024
revised:
10
06
2024
accepted:
11
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Oral squamous-cell and pancreatic carcinomas are aggressive cancers with a poor outcome. Photodynamic therapy (PDT) consists of the use of photosensitizer-induced cell and tissue damage that is activated by exposure to visible light. PDT selectively acts on cancer cells, which have an accumulation of photosensitizer superior to that of the normal surrounding tissues. 5-aminolevulinic acid (5-ALA) induces the production of protoporphyrin IX (PpIX), an endogenous photosensitizer activated in PDT. This study aimed to test the effect of a new gel containing 5%
Identifiants
pubmed: 38927525
pii: biomedicines12061316
doi: 10.3390/biomedicines12061316
pii:
doi:
Types de publication
Journal Article
Langues
eng